このページは現在、英語のみです。
データ · 医療 · インド

SS Innovations installs 30 SSi Mantra surgical robots in Q2 as revenue rises 39%

The Indian surgical robot maker has 224 systems in 12 countries, but margins fell and it is losing money again.

A surgeon positions a draped SSi Mantra robotic arm during a gallbladder removal at Medanta hospital in Gurugram.SS Innovations press image
A surgeon positions a draped SSi Mantra robotic arm during a gallbladder removal at Medanta hospital in Gurugram. SS Innovations press image · 出典

SS Innovations, the Nasdaq-listed maker of the SSi Mantra surgical robot, which is developed and built in India, reported revenue of US$13.9 million for the quarter to June, up 39.4% on the year. It installed 30 SSi Mantra systems, up from 23 a year earlier. First-half revenue rose 65.6% to US$25.0 million.

The installed base reached 224 systems across 12 countries, and 12,272 surgeries have been done on them. Gross margin fell to 50.9% from 59.1%, and the net loss widened to US$2.7 million from US$0.3 million. Cash and equivalents, excluding restricted cash, were US$13.6 million at the end of June.

SSi Mantra competes on price with Intuitive's da Vinci in Indian hospitals. The company expects the US FDA to finish reviewing its 510(k) application by the end of the first quarter of 2027. US clearance is the main test of whether an Indian-built surgical robot can sell in the biggest market.

この記事は上記の出典をもとにAIが下書きし、公開前に9DOFの編集者が確認しました。数値は出典の報道どおりです。誤りを見つけたら お知らせください 。このページで訂正します。

ウィークリー

ロボティクスとドローンを、毎週月曜日に。

ニュース · 取引 · イベント · こちらでも: TELEGRAM

メールは週に1通です。初回の配信前に確認をお願いします。いつでも配信を停止できます。

Cookie設定

必須ログイン、セキュリティ、言語、テーマ、そしてこの選択。
常にオン

ログイン

またはメールアドレスで